CompletedNCT06722079

A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome

Studying Turner syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Principal Investigator
xiaoping Luo, Doctor, L.Ac
Tongji hospital affiliated to tongji medicalcollege of huazhong university of science&technology
Enrollment
743 enrolled
Eligibility
0-18 years · FEMALE
Timeline
20222023

Study locations (1)

Collaborators

Tongji Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06722079 on ClinicalTrials.gov

Other trials for Turner syndrome

Additional recruiting or active studies for the same condition.

See all trials for Turner syndrome

← Back to all trials